4-Aryloxy-1,2,3,4-tetrahydroisoquinolines

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

546141, A61K 3147, C07D21724, C07D40106

Patent

active

043754716

ABSTRACT:
This invention relates to 4-aryloxy-1,2,3,4-tetrahydroisoquinolines of the formula ##STR1## , where Y is hydrogen and alkoxy; X is hydrogen, cyano, benzoyl, trifluoromethyl, phenyl, halogen, alkyl alkoxy and nitro; R is hydrogen and alkyl; R.sub.1 is hydrogen, alkyl, aralkyl, ##STR2## and CO.sub.2 R.sub.4 where R.sub.4 is aryl and alkyl; R.sub.2 and R.sub.3 are the same or different and are hydrogen and alkyl or R.sub.2 and R.sub.3 are fused together to form a pyrrolidino or a piperidino ring substituent; and m is an integer of 1 or 2; n is an integer of 2 or 3; and a pharmaceutically acceptable acid addition salt thereof.

REFERENCES:
patent: 3388130 (1968-06-01), Pesson
patent: 3457266 (1969-07-01), Gibas et al.
patent: 3629265 (1971-12-01), Grethe et al.
patent: 4059586 (1977-11-01), Mathison et al.
patent: 4113869 (1978-09-01), Gardner
Patent Abstract of Japan, vol. 4, No. 2, 1/9/80, p. 122c, 69[JP-A-54-138572].

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

4-Aryloxy-1,2,3,4-tetrahydroisoquinolines does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 4-Aryloxy-1,2,3,4-tetrahydroisoquinolines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 4-Aryloxy-1,2,3,4-tetrahydroisoquinolines will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1460110

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.